Oncolytics Biotech Inc. (ONC) Rating Reiterated by Royal Bank Of Canada

Oncolytics Biotech Inc. (ONC) Rating Reiterated by Royal Bank Of Canada


's stock had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada in a note issued to investors on Thursday, StockTargetPrices.com reports. Oncolytics Biotech opened at 0.27 on Thursday.



from Biotech News